Zhongqi Chen - Maxigen Biotech Director

1783 Stock  TWD 42.90  0.30  0.70%   

Director

Chen Zhongqi was Director in Maxigen Biotech Inc since June 23 2008. Chen used to be General Manager in a Shanghaibased trade company. Chen holds an Executive MBA from National Taipei University Taiwan. since 2008.
Tenure 16 years
Professional MarksMBA
Phone886 3 328 7222
Webhttps://mbi-bio.com

Maxigen Biotech Management Efficiency

The company has return on total asset (ROA) of 0.0454 % which means that it generated a profit of $0.0454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0926 %, meaning that it generated $0.0926 on every $100 dollars invested by stockholders. Maxigen Biotech's management efficiency ratios could be used to measure how well Maxigen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 16.62 M in total debt with debt to equity ratio (D/E) of 1.5, which is about average as compared to similar companies. Maxigen Biotech has a current ratio of 7.65, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Maxigen Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Maxigen Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Maxigen Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Maxigen to invest in growth at high rates of return. When we think about Maxigen Biotech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Qili LiYung Zip Chemical
N/A
Jinghui YouPhytohealth Corp
N/A
T WangPhytohealth Corp
N/A
Kunxian LinYung Zip Chemical
N/A
Zisheng WuYung Zip Chemical
N/A
Deming LuYung Zip Chemical
N/A
Mingfu WangPhytohealth Corp
N/A
Shangui LaiPhytohealth Corp
N/A
Yuru LaiPhytohealth Corp
N/A
Wenzhi HuangPhytohealth Corp
N/A
Jianxin ZhengPhytohealth Corp
N/A
Delang WuPhytohealth Corp
N/A
Chih ChienYung Zip Chemical
N/A
Fangyu LiYung Zip Chemical
N/A
Yiling LiPhytohealth Corp
N/A
Kun LinYung Zip Chemical
N/A
Deshan WangPhytohealth Corp
N/A
Yangzong CaiYung Zip Chemical
N/A
Jingzhong CaiPhytohealth Corp
N/A
Fang LeeYung Zip Chemical
53
Hongwen JiangYung Zip Chemical
N/A
Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan, Taiwan. MAXIGEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan. Maxigen Biotech (1783) is traded on Taiwan Stock Exchange in Taiwan and employs 20 people.

Management Performance

Maxigen Biotech Leadership Team

Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Haitao An, Director
Qiyu Chen, Director
PoHung Lai, Deputy Mang
WanHow You, Financial Officer
Lide Xu, Chairman of the Board
Liyan Zhang, General Manager
Changbang Zhang, Director
Xiuyuan Li, Director
Karen Lee, Sr Admin
Yamei Huang, Head of Finance
Zhiqiang Xu, CFO, Head - Finance
Sitang Deng, Independent Director
ChingTing Chen, GM Director
Yijun Huang, Deputy General Manager
Yihua You, Head of Finance & Accounting
Zhongqi Chen, Director
Qixiang Chen, Senior Deputy General Manager
Liang Zhang, Director
Shixiong Deng, Independent Director
Songqing Chen, Deputy General Manager

Maxigen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maxigen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maxigen Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Maxigen Stock analysis

When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Please note, there is a significant difference between Maxigen Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Maxigen Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maxigen Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.